DTIL (Precision BioSciences) Other Long Term Assets: $26.46 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DTIL Precision BioSciences Inc DTIL
45 GF Score
Price $7.45
GF Value $1.88
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Precision BioSciences Other Long Term Assets?

Precision BioSciences DTIL +0.27% 45 Other Long Term Assets is $26.46 Mil as of Jun. 2026. GuruFocus rates DTIL with a GF Score™ of 45/100 and a GF Value™ of $1.88 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Precision BioSciences's other long-term assets for the quarter that ended in Jun. 2026 was $26.46 Mil.

Precision BioSciences's quarterly other long-term assets increased from Dec. 2025 ($26.54 Mil) to Mar. 2026 ($34.07 Mil) but then stayed the same from Mar. 2026 ($34.07 Mil) to Jun. 2026 ($26.46 Mil).

Precision BioSciences's annual other long-term assets increased from Dec. 2023 ($5.22 Mil) to Dec. 2024 ($27.39 Mil) but then declined from Dec. 2024 ($27.39 Mil) to Dec. 2025 ($26.54 Mil).

Precision BioSciences Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Precision BioSciences's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precision BioSciences Other Long Term Assets Chart

Precision BioSciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only 11.52 19.81 5.22 27.39 26.54

Precision BioSciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.50 31.91 26.54 34.07 26.46
DTIL
45GF Score
Precision BioSciences Inc DTIL
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precision BioSciences Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $26.46 Mil mean?
Precision BioSciences (DTIL) has a Other Long Term Assets of $26.46 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Precision BioSciences and its competitors.
Is Precision BioSciences' Other Long Term Assets too high?
Precision BioSciences' current Other Long Term Assets is $26.46 Mil. Overall, Precision BioSciences has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Precision BioSciences' Other Long Term Assets compare to NERV and VYGR?
Precision BioSciences' Other Long Term Assets of $26.46 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Biotechnology company?
A good Other Long Term Assets depends on the Biotechnology industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Precision BioSciences and its competitors. Precision BioSciences's current Other Long Term Assets is $26.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision BioSciences stock overvalued right now?
Based on GuruFocus' analysis, Precision BioSciences (DTIL) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.88, compared to a current price of $7.45 — trading 296.3% above its estimated fair value. The current Other Long Term Assets is $26.46 Mil. Precision BioSciences' overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Precision BioSciences (DTIL), the current Other Long Term Assets is $26.46 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precision BioSciences (DTIL) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of $7.45 is trading 296.3% above its estimated GF Value™ of $1.88. GuruFocus considers Precision BioSciences to be Significantly Overvalued.

Key valuation signals for DTIL:

  • Other Long Term Assets: $26.46 Mil
  • GF Value™: $1.88 vs. price of $7.45 (296.3% above fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the DTIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precision BioSciences Business Description

Other Exchanges PBS0:Germany
Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
45GF Score

Get the complete analysis for DTIL

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.45
Price
$1.88
GF Value